TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/22/2024
Back to search
Official data from USPTO
VOYAGER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
07/22/2024
Trademark type
Combined
Nice classes
5, 42
Filing date
03/02/2021
Registration date
01/30/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/30/2024
Last transaction
07/22/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2022-00-00
First use in commerce
2022-00-00
Drawing code
3
Owner type
03
Owner location
Lexington, MA
Examiner
MOLINOFF, JEFFREY
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word VOYAGER. The "O" is replaced with a design comprising five circles, with three concentric circles forming the "O" and a shaded circle above and below the "O".
Holders and representatives
Holders
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc.
Representatives
Keith Toms, Esq. McCarter & English, LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biological preparations for gene therapythe treatment of Huntington's diseaseGaucher DiseaseFriedreich's ataxiaamyotrophic lateral sclerosis (ALS)Alzheimer's diseasetauopathiessynucleinopathiesneurodegenerative diseaseParkinson's disease; Biological preparations for treatment of neurological diseases and disorders; gene therapy preparations for treatment of diseaseHuntington's diseaseFriedreich's ataxiaamyotrophic lateral sclerosis (ALS)Alzheimer's diseasetauopathiessynucleinopathiesneurodegenerative diseaseParkinson's disease; treatments for neurological diseases via gene replacement or gene knockdownthe treatment of Huntington's diseaseGaucher DiseaseFriedreich's ataxiaamyotrophic lateral sclerosis (ALS)Alzheimer's diseasetauopathiessynucleinopathiesneurodegenerative diseaseParkinson's disease
Class 42
Pharmaceutical research and development in the field of gene therapy; Pharmaceutical research and development for the treatment of neurological diseases and disorders; scientific research in the field of gene therapy; pharmaceutical research services; research and development of pharmaceutical preparations for gene therapy; research and development of pharmaceutical preparations for neurological diseases; Providing medical and scientific research information in the field of clinical trials and gene therapy; Providing a website featuring information about medical research
Publications
History of USPTO decisions and trademark events.
50 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/22/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/22/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/22/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/22/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/30/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/30/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/28/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/27/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/04/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/04/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/27/2023
GNRT
NON-FINAL ACTION E-MAILED
11/27/2023
CNRT
SU - NON-FINAL ACTION - WRITTEN
11/27/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/09/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/08/2023
EX3G
SOU EXTENSION 3 GRANTED
11/08/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/08/2023
EXT3
SOU EXTENSION 3 FILED
11/03/2023
EEXT
SOU TEAS EXTENSION RECEIVED
11/03/2023
IUAF
USE AMENDMENT FILED
11/02/2023
EISU
TEAS STATEMENT OF USE RECEIVED
11/02/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/24/2023
EX2G
SOU EXTENSION 2 GRANTED
06/22/2023
EXT2
SOU EXTENSION 2 FILED
06/22/2023
EEXT
SOU TEAS EXTENSION RECEIVED
06/22/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/30/2022
EX1G
SOU EXTENSION 1 GRANTED
12/28/2022
EXT1
SOU EXTENSION 1 FILED
12/28/2022
EEXT
SOU TEAS EXTENSION RECEIVED
12/28/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/28/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/03/2022
PUBO
PUBLISHED FOR OPPOSITION
05/03/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/13/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/30/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
03/30/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/30/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
03/30/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/30/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/24/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/23/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/23/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/23/2021
GNRT
NON-FINAL ACTION E-MAILED
09/23/2021
CNRT
NON-FINAL ACTION WRITTEN
09/23/2021
DOCK
ASSIGNED TO EXAMINER
09/23/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/02/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/01/2021
NWAP
NEW APPLICATION ENTERED
03/05/2021
Continuous trademark protection
Get notified about every new filing that threatens VOYAGER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.